BRCA1 and cancer: Loss of Fhit expression was significantly more frequent in the BRCA1 cancers compared with sporadic breast tumours (9% Fhit positive vs 68% Fhit positive), suggesting that the BRCA1 pathway is also important in protecting the FRA3B/FHIT locus from damage.